Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study

Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study

Abstract Background Hemodialysis patients are prone to constipation, which can adversely affect their quality of life (QOL). Elobixibat, a highly selective inhibitor of the ileal bile acid transporter, can increase the bile acid level in the colon and, subsequently, enhance colonic motility and secr...

Full description

Bibliographic Details
Main Authors: Daigo Kamei, Yuiko Kamei, Masashi Nagano, Michio Mineshima, Kosaku Nitta, Ken Tsuchiya
Format: Article
Language:English
Published: BMC 2020-01-01
Series:BMC Gastroenterology
Subjects:
Hemodialysis patients
Constipation
Elobixibat
Bristol stool form scale
Patient assessment of constipation-quality of life questionnaire
Online Access:https://doi.org/10.1186/s12876-020-1179-6

Internet

https://doi.org/10.1186/s12876-020-1179-6

Similar Items